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論文内容の要旨  
INTRODUCTION 
Cinobufacini (also known as Huachansu), a well-known traditional Chinese medicine 
that comes from the dried skin of Bufo bufo gargarizans Cantor, has long been successfully 
used in clinic as anti-inflammatory and anticancer agents in China . Specifically, 
indolealkylamines (IAAs) and bufadienolides are two primary biologically active chemical 
components in this Chinese patent medicine. IAAs has been shown to have good anti -
inflammatory activity in LPS stimulated zebrafish coursed by LPS. The mechanism 
underlying its anti-inflammatory activity is worthy of further study. Bufadienolides are 
another kind of important effective constituents of toad skin, which has been used to treat 
patients with various types of cancers such in China. Specifically, active bufadienolide 
compounds such as hellebrigenin (Helle) and arenobufagin (Areno) exhibited better cy tocidal 
effects against a wide spectrum of cancer cell lines than other components. However, the 
cytocidal effects of Helle and Areno against breast cancer cells as well as the underlying 
molecular mechanisms remain largely unexplored.  
 The present study mainly consists of two parts as follows:  
1. Anti-inflammatory activity of IAAs and its mechanism in LPS induced zebrafish.
2. Anticancer efficacies of bufadienolide components Helle and Areno on breast cancer cells
and their underlying molecular mechanisms.  
CHAPTER ONE: Anti-inflammatory activity of IAAs and its mechanism in LPS induced 
zebrafish 
This study proved that 4 major IAAs exhibited anti -inflammatory activity on LPS induced 
zebrafish by down-regulating the level of neutrophils and pro-inflammatory cytokines (Figure 
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1). The further mechanism maybe related to the regulation of TLR4/MyD88/NF -κB and 
TLR4/MyD88/MAPKs signaling pathways as well as lipids homeostasis regulation (Figure 2). 
Enzymes especially LBP, PLA2, CERK, SMPD and SGMS were the potential therapeutic 
target for IAAs to regulate lipid homeostasis and further influence the inflamm ation pathway 
(Figure 2).  
 
Figure 1 Four IAAs inhibits recruitment of neutrophils and increase of inflammatory 
cytokines induced by LPS. After treatment with Indo (28.6 μg/ml), LPS and 4 IAAs (100 
μg/ml) for 3 h, The expression levels of inflammatory cytokine related genes were analyzed 
by Real-time quantitative PCR.  
 
Figure 2 The possibly anti-inflammatory mechanism of IAAs induced by LPS. IAAs down -
regulated lipids of SM, Cer, GluCer and PC and suppressing the inflammation pathway of 
TLR4/MyD88/NF-κB and TLR4/MyD88/MAPKs probably by acting on the enzymes like LBP, 
PLA2, CERK, SMPD and SGMS. 
CHAPTER TWO: Cytotoxicity of hellebrigenin and arenobufagin, two active bufadienolides, 
against human breast cancer cell lines MCF-7 and MDA-MB-231 
Bufadienolides, another kind of important effective constituents from cinobufacini, such 
as hellebrigenin (Helle) and arenobufagin (Areno) were demonstrated to exhibited selective 
cytocidal effects against intractable cancer cells in our previous study. th e cytocidal effects 
of Helle and Areno were investigated in human estrogen receptor (ER) -positive breast cancer 
cell line MCF-7 and triple-negative breast cancer cell line MDA-MB-231. The results showed 
that Helle exhibited more potent cytotoxicity than Ar eno in both cancer cells, and MCF-7 
cells were more susceptible to both drugs in comparison with MDA -MB-231 cells (Figure 3). 
Apoptosis and necrosis-like morphological characteristics were observed in Helle -treated 
MCF-7 cells (Figure 4-C). G2/M cell cycle arrest was also induced by Helle in the cells 
(Figure 4-D). Autophagy was triggered in MCF-7 cells and the addition of wortmannin or 3 -
MA, two well-known autophagy inhibitors, slightly but significantly rescued the cells (Figure 
4-A, B). Intriguingly, the numbers of PI-positive cells in Helle-treated MCF-7 cells were 
significantly reduced by wortmannin and 3-MA, respectively (Figure 4-C). In addition, Helle-
triggered G2/M arrest was significantly corrected by wortmannin, suggesting autophagy 
induction contributed to Helle-induced cytotoxicity of breast cancer cells by modulating 
necrosis and cell cycle arrest (Figure 4-C). Collectively, our results suggested potential 
usefulness of both Helle and Areno in developing therapeutic strategies to treat patients with 
different types of breast cancer, especially ER-positive breast cancer.  
 
Figure 3 Cytotoxic effects of Helle and Areno against human breast cancer cell lines MCF -7 
and MDA-MB-231. Cell viability was determined by WST-1 assay after treatment of MCF-7 
or MDA-MB-231 with various concentrations of Helle and Areno (1, 3, 10, 30, 100, 300 and 
1000 nM) for 48 h. Relative cell viability was calculated as the ratio of the absorbance at 450 
nm of each treatment group against those of the corresponding untreate d control group.  
 
Figure 4 Autophagy contributed to the cytotoxicity of Helle in MCF -7 cells by modulating 
apoptosis/necrosis as well as cell cycle progression. After treatment with various 
concentrations of Helle for 48 h, the expression levels of autophagy induction‑related proteins 
in MCF-7 (A) cells were analyzed by western blotting. After treatment for 48 h with Helle in 
the absence or presence of 2 μM wortmannin or 1 mM 3 -MA, cell viability was determined 
by WST-1 assay (B), the phenotypic features  of cell death were evaluated using the Hoechst 
33342 (blue)/PI (red) staining (C), cell cycle analysis was performed by FACS Canto flow 
cytometer (D). Helle, hellebrigenin. 3 -MA, 3-Methyladenine. Wort, wortmannin.  
CONCLUSION 
As the two primary biologically active chemical components, IAAs and bufadienolides 
are shown to be the major anti-inflammatory and anti-tumor active substance in cinobufacini, 
respectively. Specifically, enzymes especially LBP, PLA2, CERK, SMPD and SGMS maybe 
the potential therapeutic  target for IAAs to regulate lipid homeostasis of SM, Cer, GluCer 
and PC and further influence the inflammation pathway like TLR4/MyD88/NF -κB and 
TLR4/MyD88/MAPKs. On the other hand, as two major active bufadienolide components in 
cinobufacini, Helle exhibited more potent cytotoxicity than Areno in different types of breast 
cancer, especially ER-positive breast cancer. Besides, in addition to apoptosis induction, 
autophagy appeared to contribute to the cytotoxicity of Helle by modulating both necrosis 
and cell cycle arrest in MCF-7 cells.  
Given inseparable relationship between cancer development and inflammation, natural 
products like IAAs and bufadienolides from cinobufacini may provide a potential new 
strategy as combinational and/or complimentary therapi es for cancer treatment.  
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論文審査の結果の要旨 
 










第 1 章では LPS 処置により炎症を惹起させたゼブラフィッシュに対して 4 つの主要な IAAs
（N-methyl serotonin, bufotenine, dehydrobufotenine, and bufothionine）は好中球数を減少さ
せ、かつ炎症性サイトカインレベルを抑制することで抗炎症作用を発揮することが明らかとなっ
た。さらに、その機序として、mRNA の解析により、 TLR4/MyD88/NF-B および
TLR4/MyD88/MAPK のシグナル伝達経路の抑制、ならびに lipid profiling の解析により脂質の
恒常性調節が寄与すると示唆された。とりわけ、LBP（LPS-binding protein）、PLA2、CERK
（ceramide transport kinase）、SMPD（sphingomyelin phosphodiesterase）および SGMS
（sphingolipid synthetase）は IAAs の有力な治療標的であり、これらを介して脂質ホメオスタ
シスを調節し炎症経路に影響を及ぼしていると考えられた。 
第 2 章では、cinobufacini の抗腫瘍活性に着目した。特に乳がん細胞に対する効果とそのメカ







特に ER陽性乳がん患者に対する Helleと Arenoの有用性を示唆するものである。 
本研究では、アジアヒキガエルの乾燥皮膚から抽出される cinobufacini の主要な生物活性成分
IAAs が TLR4/MyD88/NF-B および TLR4/MyD88/MAPK のシグナル伝達経路を抑制し抗炎症
作用を発揮し、これらの抗炎症効果には脂質ホメオスタシスの調節も寄与する可能性を示した。
その一方で、bufadienolide はその活性物質 Helle と Areno が乳がん細胞に対する抗腫瘍効果を
発揮し、特に Helle はアポトーシス誘導の他にオートファジーを介したネクローシス誘導と細胞
周期の停止を惹起していることを明らかにした。 
 以上本申請論文は、cinobufacini 由来の主要生物活性物質の新たな治療標的とその作用機序を
明らかにし、種々のがん治療戦略を構築する上で基礎研究の視点から有益な知見を与えるもので
ある。よって、博士（薬学）学位論文として相応しいものと判断する。 
 
